Antonio G. M.
- Country
- Spain
- Department
- Department of Gynecology
Research Overview
Data & Insights
Has run more than one trial at 0 of 10 partner sites.
Specializations
Gynecologic Oncology
Dr. Gil‑Moreno directs studies on malignancies of the female reproductive system, emphasizing biologically driven therapies.
- Advanced breast cancer
- ovarian cancer
- endometrial carcinoma
- cervical squamous cell carcinoma
- vulvar squamous cell carcinoma
Trials integrate hormonal, HER2‑targeted and immunotherapeutic strategies.
Hematologic Oncology
Research encompasses acute and chronic blood cancers, focusing on novel agents and transplant‑related outcomes.
- acute myeloid leukemia
- myelodysplastic syndrome
- chronic lymphocytic leukemia
- follicular lymphoma
- multiple myeloma
Efforts address measurable residual disease and post‑transplant graft‑versus‑host disease.
Molecularly Targeted Solid Tumors
Investigations target actionable genomic alterations across diverse solid cancers.
- KRAS‑mutated tumors
- HER2‑positive cancers
- EGFR‑mutant lung cancer
- IDH‑mutant glioma
- ALK‑rearranged non‑small cell lung cancer
Biomarker‑driven enrollment supports precision‑medicine approaches.
Autoimmune and Systemic Inflammatory Disorders
Clinical studies explore mechanisms and therapies for immune‑mediated diseases.
- systemic lupus erythematosus
- rheumatoid arthritis
- psoriatic arthritis
- cutaneous lupus
- immune thrombocytopenia
Interventions include biologics and small‑molecule modulators.
Infectious and Pulmonary Conditions
Trials address chronic lung infections and obstructive airway diseases.
- nontuberculous mycobacterial lung infection
- obstructive sleep apnea
- severe asthma
- COVID‑19
- acute bacterial skin infection
Outcomes focus on microbial clearance and respiratory function improvement.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.